Measles-containing-vaccine second-dose (MCV2) immunization coverage in Serbia
Serbia: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 91.0% in 2025. ▬ Flat
Latest (2025)
91.0%
Change on year
unchanged
World rank
66th
of 194 countries
All-time high
98.0%
in 2005
All-time low
74.0%
in 2001
Years of data
26
2000–2025
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Serbia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in Serbia is 91.0%, measured in 2025.
Compared with earlier readings it is up 4.6% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Serbia peaked at 98.0% in 2005 and was at its lowest, 74.0%, in 2001.
Serbia ranks 66th of 194 countries on this measure, in the middle of the range.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Serbia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 78.0% | — |
| 2001 | 74.0% | -5.1% |
| 2002 | 75.0% | +1.4% |
| 2003 | 96.0% | +28.0% |
| 2004 | 96.0% | +0.0% |
| 2005 | 98.0% | +2.1% |
| 2006 | 90.0% | -8.2% |
| 2007 | 96.0% | +6.7% |
| 2008 | 97.0% | +1.0% |
| 2009 | 87.0% | -10.3% |
| 2010 | 91.0% | +4.6% |
| 2011 | 90.0% | -1.1% |
| 2012 | 90.0% | +0.0% |
| 2013 | 82.0% | -8.9% |
| 2014 | 91.0% | +11.0% |
| 2015 | 87.0% | -4.4% |
| 2016 | 90.0% | +3.4% |
| 2017 | 91.0% | +1.1% |
| 2018 | 90.0% | -1.1% |
| 2019 | 91.0% | +1.1% |
| 2020 | 84.0% | -7.7% |
| 2021 | 86.0% | +2.4% |
| 2022 | 89.0% | +3.5% |
| 2023 | 91.0% | +2.2% |
| 2024 | 91.0% | +0.0% |
| 2025 | 91.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 88.7% | 74.0% | 98.0% | 10 |
| 2010s | 89.3% | 82.0% | 91.0% | 10 |
| 2020s | 88.7% | 84.0% | 91.0% | 6 |
Countries ranked near Serbia
More health data for Serbia
- Un projection of annual infant deaths, annual growth rate -5.26 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3584 % change on previous year (2090)
- Heat deaths vs projected death rates 1,502 (2090)
- Un projection of annual infant deaths 18 (2100)
- Population ages 65 and above, female, annual growth rate 1.39 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.1355 units per person (2025)
- Population ages 65 and above, male, annual growth rate 0.52 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0951 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Serbia?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Serbia was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Serbia?
- The highest recorded value was 98.0% in 2005.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Serbia?
- The lowest recorded value was 74.0% in 2001.
- How does Serbia rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Serbia ranks 66th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Serbia?
- Over the last ten years it is up 4.6%. The long-run trend across the full record is flat.
- Where does this Serbia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).